-
Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
Lo Presti, V., Meringa, A., Dunnebach, E., van Velzen, A., Moreira, A. V., Stam, R. W., Kotecha, R. S., Krippner-Heidenreich, A., Heidenreich, O. T., Plantinga, M., Cornel, A., Sebestyen, Z., Kuball, J., van Til, N. P. & Nierkens, S., 5 Apr 2024, In: Journal for Immunotherapy of Cancer. 12, 4, e008174.Research output: Contribution to journal › Article › Academic › peer-review
-
Efficient lentiviral transduction method to gene modify cord blood CD8+ T cells for cancer therapy applications
Lo Presti, V., Cornel, A. M., Plantinga, M., Dünnebach, E., Kuball, J., Boelens, J. J., Nierkens, S. & van Til, N. P., 11 Jun 2021, In: Molecular therapy. Methods & clinical development. 21, p. 357-368Research output: Contribution to journal › Article › Academic › peer-review
-
Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors
Lo Presti, V., Buitenwerf, F., van Til, N. P. & Nierkens, S., 3 Dec 2020, In: Vaccines. 8, 4Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
